(Q36753020)

16 August 2017

Activity of temafloxacin against respiratory pathogens (English)

1 reference

16 August 2017

Swanson RN

1

1 reference

16 August 2017

Hardy DJ

2

1 reference

16 August 2017

Chu DT

3

1 reference

16 August 2017

Shipkowitz NL

4

1 reference

16 August 2017

Clement JJ

5

1 reference

16 August 2017

language of work or name

English

0 references

publication date

1 March 1991

1 reference

16 August 2017

7

1 reference

Antimicrobial Agents and Chemotherapy

inferred from page(s)

published in

1 reference

16 August 2017

35

1 reference

16 August 2017

3

1 reference

16 August 2017

423-429

1 reference

Experimental otitis media in gerbils and chinchillas with Streptococcus pneumoniae, Haemophilus influenzae, and other aerobic and anaerobic bacteria

16 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245026

Susceptibility of Legionella pneumophila to ofloxacin in vitro and in experimental Legionella pneumonia in guinea pigs

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245026

In vivo evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245026

Comparative antibacterial activities of temafloxacin hydrochloride (A-62254) and two reference fluoroquinolones

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245026

Efficacy of NY-198 against experimental Legionnaires disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245026

The in-vitro activity, pharmacokinetics and tissue penetration of temafloxacin

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245026

Quinolones in the treatment of lower respiratory tract infections

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245026

Comparison of ciprofloxacin and rifampicin in experimental Legionella pneumophila pneumonia

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245026

Correlation of in vitro activities of the fluoroquinolones to their in vivo efficacies.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245026

Comparative in vitro activity of the new difluoro-quinolone temafloxacin (A-62254) against bacterial isolates from cancer patients.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245026

In-vitro activities of temafloxacin, tosufloxacin (A-61827) and five other fluoroquinolone agents.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245026

Efficacy of pefloxacin in comparison with erythromycin in the treatment of experimental guinea pig legionellosis

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245026

The antimicrobial activity of ciprofloxacin against Legionella species and the treatment of experimental Legionella pneumonia in guinea pigs

5 September 2018

1 reference

12 December 2020

In vitro activity of temafloxacin, a new difluoro quinolone antimicrobial agent

1 reference

12 December 2020

Fluoroquinolone antimicrobial agents

1 reference

12 December 2020

Studies on ciprofloxacin therapy of experimental Legionnaires' disease

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.35.3.423

1 reference

16 August 2017

1 reference

16 August 2017

PubMed publication ID

2039192

1 reference